Clinical research

Veeva Vault alternatives for clinical trials in 2026

Seven Veeva Vault alternatives for clinical trials, compared by what they replace, who they suit and where they fall short.

Prasanna Gopinath, Founder and CEO, Mahalo Health7 min read
A clinical operations manager and a study coordinator review a wall of printed study system maps in a hospital research office.

Mahalo Health publishes this guide and is one of the options in it. We built it in November 2026 from each vendor's public product pages, Veeva's own platform guidance, and Veeva reviews on G2 and Capterra. We did not run hands-on tests of other vendors' software. The comparisons are our opinion.

Mahalo Research trial master file dashboard showing completeness by TMF zone, a filing queue and inspection readiness for a fictional study, beside a TMF lead's phone.

Key takeaways

  • "Veeva Vault" covers several clinical products: eTMF, CTMS, EDC and CDMS, RTSM, eCOA, Study Startup, Payments and the free SiteVault eISF for sites. Decide which of them you are replacing before you compare vendors.
  • Teams usually look elsewhere for three reasons: the size of an enterprise implementation, the admin effort to keep it configured, and quote-based pricing that assumes a large sponsor.
  • Mahalo Health replaces nine trial systems on one participant record, adds EHR-based patient recruitment, and keeps participants on the same record if they move into a care program after the study.
  • If you only need data capture, focused EDC vendors such as Medrio, Viedoc, Castor and OpenClinica are lighter options. Medidata and Oracle Clinical One are the enterprise alternatives.
  • Veeva remains a strong choice for large sponsors that have standardised documents, operations and staff on Vault.

The short answer

Pick by the problem you are solving. If your team loses time reconciling separate systems, finding patients, or handing participants over to care after a study, choose a unified platform such as Mahalo Health. If you need an enterprise EDC with deep libraries for large global programmes, compare Medidata and Oracle Clinical One. If you only need data capture for smaller studies, look at Medrio, Viedoc, Castor or OpenClinica.

What Veeva does well

The Veeva Clinical Platform covers clinical operations (eTMF, CTMS, Payments, Study Startup, Site Connect, Study Training, Disclosures), clinical data (EDC and DQS), RTSM, eCOA, a free eISF for sites (SiteVault), single sign-on for researchers (VeevaID) and a patient app (MyVeeva for Patients) (Veeva).

Veeva's own guidance describes one large biopharma retiring over 100 systems on the platform (Veeva eBook). On G2, reviewers credit Vault for unified CTMS and eTMF, audit readiness and strong document management (G2). For a sponsor that already runs its documents and operations on Vault, those are real reasons to stay.

Why teams look for Veeva alternatives

  • Implementation time. Veeva describes a global biotech whose primary implementation took one year after the discovery phase, with the first study live within six months (Veeva eBook). That pace suits a portfolio, not a single urgent study.
  • Learning curve and admin effort. G2 reviewers mention rigid lifecycle workflows, many clicks to file eTMF documents, and custom reports that need a power user or system admin (G2).
  • Cost for smaller teams. A Capterra reviewer calls Vault "a bit expensive for companies that are just starting off or are small" (Capterra). We did not find a public price list on veeva.com, so budgets start with a sales quote.
  • What sits outside the platform. Finding patients in site EHRs and running care programs after the study still mean extra vendors and a new record for the same person.

The best Veeva alternatives in 2026

1. Mahalo Health: one record from recruitment to care

Mahalo Health is a clinical research and connected care platform. Mahalo Research replaces nine systems studies usually buy separately: EDC; CTMS for sponsor and site; eTMF and the site's own eISF; randomization and trial supply; eCOA and ePRO; eConsent; site eSource; site training records; and randomization by phone. It runs the workflow for central labs, site payments and enterprise pharmacovigilance while your partner keeps their system, and it connects to the EHR and to regulator and ethics portals.

  • Mahalo Intelligence reads the approved protocol and drafts the study build: forms, visits and edit checks. Your designer confirms each element before anything runs.
  • Recruit screens authorized EHR charts nightly against the approved protocol rules and shows the evidence for every match. A named person verifies every match. It connects to Epic, Oracle Cerner, athenahealth, eClinicalWorks, NextGen, ModMed, Veradigm, Greenway and MEDENT.
  • Mahalo Care runs remote patient monitoring, remote therapeutic monitoring, chronic care management and virtual care on the same record, so a participant can move from a study into a care program without starting over.
  • Certified to ISO/IEC 27001:2022 and ISO 9001:2015. Configurable controls support 21 CFR Part 11 and ICH E6 GCP workflows.

Best for: sponsors, CROs, academic teams and health systems that want to start with one study, find patients in site EHRs, or keep participants connected after the study.

Limitations: Mahalo works with central labs and enterprise pharmacovigilance rather than replacing them. Programmes built around central imaging or endpoint adjudication may be better served by Medidata.

Inside Mahalo Research · 6 screens

Documents, data and sites on one record.

Six screens from one study, from protocol upload to inspection and care. Drag to explore.

Phone screen showing a protocol upload that starts a draft study build.
01

Build from protocol

Upload the protocol and Mahalo Intelligence drafts the study build for review.

Phone screen showing one participant record with eConsent, EDC visits, eCOA, devices and a care program.
02

One participant record

eConsent, EDC, eCOA, devices and care all sit on one participant ID.

Phone screen showing documents filed to TMF sections this week, with some waiting for confirmation.
03

Filed automatically

Documents created by study activity land in the right TMF section.

Phone screen showing site activation progress across 24 sites.
04

Site activation

See training, documents and system access for each site before activation.

Phone screen showing inspection readiness and time-limited, read-only inspector access.
05

Inspection readiness

Readiness is checked live, and inspectors get time-limited, read-only access.

Phone screen showing study close-out with locked data and a step to move into care.
06

Study close-out

Study data locks for analysis, and history carries into care without re-entry.

2. Medidata: the enterprise EDC benchmark

Rave EDC is the centre of the Medidata Platform. Medidata says Rave aggregates and reconciles data from eConsent, eCOA, RTSM and imaging, and reports 1.8 million users and more than 38,000 studies on Rave EDC (Medidata).

Best for: large global drug programmes, especially where central imaging or endpoint adjudication sit at the centre of the study. Limitations: an enterprise purchase with an enterprise implementation; G2 reviewers mention high cost for small companies (G2).

3. Oracle Clinical One: data collection and RTSM on one platform

Oracle says Clinical One Data Collection captures data from EHRs, labs and patient applications on a single platform, and Clinical One RTSM handles randomization and trial supply on the same platform (Oracle).

Best for: sponsors that want data collection and randomization from one enterprise vendor. Limitations: the page we cite covers data collection and randomization only, so check which document and operations tools (eTMF, CTMS) you would still need.

4. Castor: EDC, eCOA and eConsent with AI extraction

Castor offers EDC, eCOA, eConsent and data management in one platform. Its Catalyst product uses AI to turn source documents and EHR data into structured records, and a human reviewer confirms every result. Castor reports 19,000+ studies and 900+ customers (Castor).

Best for: biotech, medtech and academic teams that want a self-service data platform. Limitations: its home page lists no CTMS or eTMF, so plan for operations to stay in other tools.

5. Medrio: no-code EDC for small and scaling teams

Medrio positions itself as the EDC for small and scaling clinical teams, with integrated EDC/CDMS, ePRO/eCOA, eConsent and RTSM that sponsors can configure without a programmer (Medrio).

Best for: small sponsors and CROs running studies without in-house programmers. Limitations: focused on clinical data; documents and site operations need other tools.

6. Viedoc: predictable, per-study pricing

Viedoc offers EDC, ePRO and televisits, prices per study with no per-seat fees, and reports a 10-week average study build (Viedoc).

Best for: teams that need a predictable budget for data capture. Limitations: a data-capture suite, not a replacement for Vault's eTMF or CTMS.

7. OpenClinica: modular eClinical for academic and mid-size teams

OpenClinica combines EDC, eConsent, eCOA, randomization, EHR-to-EDC, analytics and patient recruitment, and names university researchers, academic medical centers, sponsors and CROs among its users (OpenClinica).

Best for: investigator-initiated studies and small to mid-size sponsors. Limitations: its home page lists no eTMF or CTMS, so documents and operations stay in other tools.

Side-by-side comparison

Veeva Vault alternatives compared on vendor-published capabilities (November 2026)
OptionBest forTrial systems covered (vendor-stated)EHR patient recruitmentCare programs after the study
Veeva Clinical PlatformLarge sponsors standardised on VaulteTMF, CTMS, EDC and CDMS, RTSM, eCOA, Study Startup, Payments, SiteVault eISFNot on the platform pageNot on the platform page
Mahalo HealthStarting with one study; site-heavy or care-linked studiesEDC, CTMS, eTMF and eISF, RTSM, eCOA and ePRO, eConsent, site eSource, training recordsYes, with RecruitYes, with Mahalo Care
MedidataLarge global drug programmesRave EDC with eConsent, eCOA, RTSM and imaging dataNot on the Rave EDC pageNot on the pages cited
Oracle Clinical OneEnterprise data collection plus RTSMData collection, RTSMNot on the page citedNot on the pages cited
CastorSelf-service biotech, medtech and academic studiesEDC, eCOA, eConsent, AI data extractionNot on the home pageNot on the pages cited
MedrioSmall and scaling teamsEDC/CDMS, ePRO/eCOA, eConsent, RTSMNot on the home pageNot on the pages cited
ViedocPredictable per-study budgetsEDC, ePRO, televisitsNot on the home pageNot on the pages cited
OpenClinicaAcademic and mid-size teamsEDC, eConsent, eCOA, randomization, EHR-to-EDCPatient recruitment moduleNot on the pages cited

How to switch without disrupting live studies

  1. List which Vault applications you use today and which study each one supports.
  2. Keep live studies where they are. Moving a study mid-flight adds validation and reconciliation work.
  3. Pick one new study for the new platform and bring its protocol, data-management plan and system list to the evaluation.
  4. Agree which partner systems stay (central labs, safety database, regulator portals) and how data reaches them.
  5. Plan document retention for studies that close on Vault before you change contracts.

For a deeper look at how a single platform compares with a stack built around Medidata or Veeva, read Mahalo Health vs. multi-vendor clinical trial stacks built on Medidata and Veeva.

See it on your own protocol

Bring a protocol and your current Vault footprint. We'll map what Mahalo replaces, what it runs with your partners and what stays where it is.

Book a demo

Sources

Frequently asked questions

What is the best alternative to Veeva Vault for clinical trials?
It depends on what you are replacing. For one record across the trial, EHR-based recruitment and care after the study, Mahalo Health. For an enterprise EDC on large global programmes, Medidata or Oracle Clinical One. For lighter data capture, Medrio, Viedoc, Castor or OpenClinica.
Does Mahalo Health replace Veeva eTMF and CTMS?
Yes. Mahalo Research replaces eTMF and the site's own eISF, and CTMS for sponsor and site, together with EDC, randomization and trial supply, eCOA and ePRO, eConsent, site eSource and site training records, on one participant record.
Can I keep Veeva for some studies and use Mahalo for others?
Yes. Many teams keep live studies where they are and start one new study on Mahalo. Mahalo hands off to central labs, enterprise pharmacovigilance and regulator portals rather than replacing them.
How long does it take to start on Mahalo Health?
Mahalo starts with one defined study, then adds integrations, validation support and multi-country scale as the programme grows. Mahalo Intelligence drafts the study build from the approved protocol, and your designer confirms each element.

Move from insight to implementation

Explore the Mahalo workflow most closely aligned with this article, or discuss a regulated deployment with the team.